Hou Bingbing, Lin Yanwei, Wu Haizhen, Guo Meijin, Petkovic Hrvoje, Tao Liyuan, Zhu Xiaoyu, Ye Jiang, Zhang Huizhan
State Key Laboratory of Bioreactor Engineering, East China University of Science and Technology, Shanghai, China.
Department of Applied Biology, East China University of Science and Technology, Shanghai, China.
J Bacteriol. 2017 Dec 20;200(2). doi: 10.1128/JB.00447-17. Print 2018 Jan 15.
Lincomycin A is a clinically important antimicrobial agent produced by In this study, a new regulator designated LmbU (GenBank accession no. ABX00623.1) was identified and characterized to regulate lincomycin biosynthesis in wild-type strain NRRL 2936. Both inactivation and overexpression of resulted in significant influences on lincomycin production. Transcriptional analysis and neomycin resistance (Neo) reporter assays demonstrated that LmbU activates expression of the , , , and genes and represses expression of the and genes. Electrophoretic mobility shift assays (EMSAs) demonstrated that LmbU can bind to the regions upstream of the and genes through the consensus and palindromic sequence 5'-CGCCGGCG-3'. However, LmbU cannot bind to the regions upstream of the , , , and genes as they lack this motif. These data indicate a complex transcriptional regulatory mechanism of LmbU. LmbU homologues are present in the biosynthetic gene clusters of secondary metabolites of many other actinomycetes. Furthermore, the LmbU homologue from (GenBank accession no. WP_009944629.1) also binds to the regions upstream of and , which suggests widespread activity for this regulator. LmbU homologues have no significant structural similarities to other known cluster-situated regulators (CSRs), which indicates that they belong to a new family of regulatory proteins. In conclusion, the present report identifies LmbU as a novel transcriptional regulator and provides new insights into regulation of lincomycin biosynthesis in Although lincomycin biosynthesis has been extensively studied, its regulatory mechanism remains elusive. Here, a novel regulator, LmbU, which regulates transcription of its target genes in the lincomycin biosynthetic gene cluster ( gene cluster) and therefore promotes lincomycin biosynthesis, was identified in strain NRRL 2936. Importantly, we show that this new regulatory element is relatively widespread across diverse actinomycetes species. In addition, our findings provide a new strategy for improvement of yield of lincomycin through manipulation of LmbU, and this approach could also be evaluated in other secondary metabolite gene clusters containing this regulatory protein.
林可霉素A是由[具体产生菌未提及]产生的一种临床上重要的抗菌剂。在本研究中,鉴定并表征了一种名为LmbU(GenBank登录号ABX00623.1)的新调控因子,其可调控野生型菌株NRRL 2936中林可霉素的生物合成。LmbU的失活和过表达均对林可霉素的产生有显著影响。转录分析和新霉素抗性(Neo)报告基因检测表明,LmbU激活了[具体基因未提及]、[具体基因未提及]、[具体基因未提及]和[具体基因未提及]基因的表达,并抑制了[具体基因未提及]和[具体基因未提及]基因的表达。电泳迁移率变动分析(EMSA)表明,LmbU可通过共有回文序列5'-CGCCGGCG-3'与[具体基因未提及]和[具体基因未提及]基因上游区域结合。然而,LmbU不能与[具体基因未提及]、[具体基因未提及]、[具体基因未提及]和[具体基因未提及]基因上游区域结合,因为它们缺乏该基序。这些数据表明LmbU存在复杂的转录调控机制。LmbU同源物存在于许多其他放线菌次级代谢产物的生物合成基因簇中。此外,来自[具体菌株未提及]的LmbU同源物(GenBank登录号WP_009944629.1)也与[具体基因未提及]和[具体基因未提及]上游区域结合,这表明该调控因子具有广泛的活性。LmbU同源物与其他已知的簇状调控因子(CSR)没有明显的结构相似性,这表明它们属于一个新的调控蛋白家族。总之,本报告鉴定LmbU为一种新型转录调控因子,并为[具体菌株未提及]中林可霉素生物合成的调控提供了新的见解。尽管林可霉素的生物合成已得到广泛研究,但其调控机制仍不清楚。在此,在菌株NRRL 2936中鉴定了一种新型调控因子LmbU,其可调控林可霉素生物合成基因簇([具体基因簇未提及]基因簇)中靶基因的转录,从而促进林可霉素的生物合成。重要的是,我们表明这种新的调控元件在不同的放线菌物种中相对广泛存在。此外,我们的研究结果为通过操纵LmbU提高林可霉素产量提供了一种新策略,并且这种方法也可在含有该调控蛋白的其他次级代谢产物基因簇中进行评估。